A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI)

被引:43
|
作者
Burke, Peter Thomas [1 ]
Ghanbari, Hamid [1 ]
Alexander, Patrick B. [1 ]
Shaw, Michael K. [1 ]
Daccarett, Marcos [1 ]
Machado, Christian [1 ]
机构
[1] Providence Hosp, Providence Heart Inst, Southfield, MI 48075 USA
关键词
Magnetic resonance imaging; MRI; Cardiac implantable electronic device; CIED; Pacemaker; ICD; Defibrillator threshold testing; Defibrillation safety margin testing; DSMT; CARDIOVERTER-DEFIBRILLATORS; CARDIAC-PACEMAKERS; 1.5; TESLA; VENTRICULAR-FIBRILLATION; PERMANENT PACEMAKERS; SCIENTIFIC STATEMENT; IN-VITRO; SAFETY; CONVERSION; 1.5-TESLA;
D O I
10.1007/s10840-009-9463-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Magnetic resonance imaging (MRI) in patients with Cardiovascular Implantable Electronic Devices (CIED) has not been approved by the Food and Drug Administration. Recent data suggests MRI as a relative rather than absolute contraindication in CIED patients. Recently, the American Heart Association has recommended defibrillation threshold testing (DFTT) in implantable cardioverter defibrillator (ICD) patients undergoing MRI. We evaluated the feasibility and safety of a protocol for MRI in CIED patients, incorporating the new recommendations on DFTT. Consecutive patients with CIED undergoing MRI were included. The protocol consisted of continuous monitoring during imaging, device interrogation pre- and post-MRI, reprogramming of the pacemaker to an asynchronous mode in pacemaker-dependent (PMD) patients and a non-tracking/sensing mode for non-PMD patients. All tachyarrhythmia therapies were disabled. Devices were interrogated for lead impedance, battery life, pacing, and sensing thresholds. All patients with ICD underwent DFTT/defibrillator safety margin testing (DSMT) post-MRI. A total of 92 MRI's at 1.5 Tesla were performed in 38 patients. A total of 13 PMD patients, ten ICD patients, four cardiac resynchronization therapy with defibrillator (CRT-D) patients, and 11 non-PMD patients were scanned from four major manufacturers. No device circuitry damage, programming alterations, inappropriate shocks, failure to pace, or changes in sensing, pacing, or defibrillator thresholds were found on single or multiple MRI sessions. Our protocol for MRI in CIED patients appears safe, feasible, and reproducible. This is irrespective of the type of CIED, pacemaker dependancy or multiple 24-h scanning sessions. Our protocol addresses early detection of potential complications and establishes a response system for potential device-related complications. Our observation suggests that routine DFTT/DSMT post-MRI may not be necessary.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 50 条
  • [41] Prognostic significance of magnetic resonance imaging (MRI) of bone marrow (BM) in patients with multiple myeloma (MM) undergoing treatment with high-dose melphalan (HDM) and autologous stem cell transplantation (ASCT).
    Anagnostopoulos, Athanasios
    Moulopoulos, Lia A.
    Roussou, Maria
    Kastritis, Efstathios
    Gika, Dimitra
    Bozas, George
    Stefanoudaki, Aikaterini
    Anagnostopouios, Nikolaos
    Vassou, Amalia
    Bourantas, Konstantinos
    Dimopoulos, Meletios A.
    BLOOD, 2006, 108 (11) : 882A - 882A
  • [43] Assessing the SAfety and FEasibility of bedside portable low-field brain Magnetic Resonance Imaging in patients on ECMO (SAFE-MRI ECMO study): study protocol and first case series experience
    Sung-Min Cho
    Christopher Wilcox
    Steven Keller
    Matthew Acton
    Hannah Rando
    Eric Etchill
    Katherine Giuliano
    Errol L. Bush
    Haris I. Sair
    John Pitts
    Bo Soo Kim
    Glenn Whitman
    Critical Care, 26
  • [44] Assessing the SAfety and FEasibility of bedside portable low-field brain Magnetic Resonance Imaging in patients on ECMO (SAFE-MRI ECMO study): study protocol and first case series experience
    Cho, Sung-Min
    Wilcox, Christopher
    Keller, Steven
    Acton, Matthew
    Rando, Hannah
    Etchill, Eric
    Giuliano, Katherine
    Bush, Errol L.
    Sair, Haris, I
    Pitts, John
    Kim, Bo Soo
    Whitman, Glenn
    CRITICAL CARE, 2022, 26 (01)
  • [45] Factors Associated with the Decision of the Rheumatologist to Order Sacro-Iliac Joints Magnetic Resonance Imaging (SI-MRI) or Order HLA-B27 Testing in Patients with Spondyloarthritis in Clinical Practice
    Bautista-Molano, Wilson
    Landewe, Robert
    Serna, Cesar
    Valle, Rafael R.
    van der Heijde, Desiree
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [46] Factors associated with the decision of the rheumatologist to order sacroiliac joints magnetic resonance imaging (SI-MRI) or HLA-B27 testing in the diagnostic work-up of patients with spondyloarthritis in clinical practice
    Bautista-Molano, W.
    Landewe, R. B. M.
    Serna, C.
    Valle-Onate, R.
    van der Heijde, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (01) : 122 - 128
  • [47] Persistence of magnetic resonance imaging (MRI) abnormalities post-transplantation does not predict for early relapse in multiple myeloma (MM) patients who achieved complete remission after double autologous stem cell transplants.
    Jazieh, AR
    Antguaco, E
    Bracy, D
    Mattox, S
    Peterson, L
    Jagannath, S
    Barlogie, B
    Desikan, KR
    Siegel, D
    Tricot, G
    BLOOD, 1996, 88 (10) : 1567 - 1567
  • [48] Prospective, randomized, double-blind, double-dummy, active-controlled, phase 3 clinical trial comparing the safety and efficacy of intranasal dexmedetomidine to oral midazolam as premedication for propofol sedation in pediatric patients undergoing magnetic resonance imaging: the MIDEX MRI trial
    Wabelo, Olivia Nzungu
    Schmartz, Denis
    Giancursio, Mario
    De Pooter, Francoise
    Caruso, Giulia
    Fils, Jean-Francois
    Van der Linden, Philippe
    TRIALS, 2023, 24 (01)
  • [49] Prospective, randomized, double-blind, double-dummy, active-controlled, phase 3 clinical trial comparing the safety and efficacy of intranasal dexmedetomidine to oral midazolam as premedication for propofol sedation in pediatric patients undergoing magnetic resonance imaging: the MIDEX MRI trial
    Olivia Nzungu Wabelo
    Denis Schmartz
    Mario Giancursio
    Françoise De Pooter
    Giulia Caruso
    Jean-François Fils
    Philippe Van der Linden
    Trials, 24
  • [50] A prospective study to evaluate the role of 2-[18f] fluoro-2-deoxy- d-glucose (FDG)-positron emission tomography (PET), breast magnetic resonance imaging (MRI), and breast ultrasonography in monitoring tumor responses in patients with locally advanced breast cancer (LABC) undergoing neoadjuvant chemotherapy.
    Mukherjee, S. D.
    Dhamanaskar, K.
    Tozer, R.
    Hodgson, N.
    MacGillivray, M.
    Gu, C.
    Cline, K.
    Elavathil, L.
    Julian, J.
    Gulenchyn, K. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)